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Abstract
Background The sentinel lymph node (SLN) procedure
alter the strategy for the treatment of patients with colon
cancer. New techniques emerge that may provide the sur-
geon with a tool for accurate intraoperative detection of the
SLNs.
Methods An SLN procedure of the sigmoid was used in
six goats. During laparoscopy, the near-infrared dye indo-
cyanine green (ICG) was injected into the subserosa of the
sigmoid via a percutaneously inserted needle during four
experiments and in the submucosa during colonoscopy in
two experiments. After injection, the near-infrared features
of a newly developed laparoscope were used to detect the
lymph vessels and SLNs. At the end of the procedure, 2 h
after injection, all the goats were killed, and autopsy was
performed. During postmortem laparotomy, the sigmoid
was removed and used for confirmation of ICG node
uptake.
Results In all the procedures, the lymph vessels were
easily detected by their bright fluorescent emission. In the
first two experiments, no lymph nodes were detected. In the
subsequent four experiments, human serum albumin was
added to the ICG solution before injection to enable better
lymph node entrapment. In all four experiments, at least
one bright fluorescent lymph node was found after the
lymph vessels had been tracked by their fluorescent guid-
ance. The mean time between injection and SLN identifi-
cation was 10 min. In two cases, the SLNs were located up
to 5 mm into the fat tissue of the mesentery and were not
seen by regular vision of the laparoscope. By switching on
the near-infrared features of the scope, a clear bright dot
became visible, which increased in intensity after opening
of the mesentery.
Conclusion The SLN procedure for the sigmoid using
near-infrared laparoscopy in the goat is a very promising
technique. Achievements described in this report justify a
clinical trial on the feasibility of ICG-guided SLN detec-
tion in humans.
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Colorectal cancer (CRC) is a leading cause of cancer-
related deaths worldwide. Each year, approximately
500,000 patients die of colorectal malignancy [1]. The
management of CRC has not changed for more than
100 years. The metastatic status of regional lymph nodes
remains one of the most important factors for determining
adjuvant chemotherapy.
Stages 1 and 2 colorectal cancer imply no lymph node
involvement. However, up to 30% of the patients will
experience locoregional recurrence or distant metastases
and will die eventually of CRC. Therefore, standard sur-
gery might not be sufficient for these patients [2]. A sub-
stantial portion of these patients will experience
recurrences due to inadequate lymph node resection or
missed nodal metastases at histologic examination [3].
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With conventional hematoxylin and eosin (H&E)
staining, micrometastases are not detected. When the
lymph node is multisectioned, micrometastases can be
detected by immunohistochemistry and reverse transcrip-
tase–polymerase chain reaction (RT–PCR). These tech-
niques are labor and cost intensive, so it is highly
impractical to ultrastage all the nodes in a given specimen.
Several studies indicate that micrometastases are correlated
with a significantly worse prognosis [4–7]. The sentinel
lymph node (SLN) procedure could improve accurate
staging by providing the pathologist with one or two lymph
nodes for detailed evaluation. Also, a reliable sentinel node
harvesting technique may alter the management in colo-
rectal cancer treatment [2].
Several studies concerning the feasibility of SLN map-
ping in colon carcinoma have been published. The conclu-
sion of a metaanalysis published in 2007 is that lymphatic
mapping appears to be readily applicable. Its global sensi-
tivity and specificity were, respectively, 70 and 81% [8].
Due to the wide variation of results shown in the liter-
ature, SLN mapping should be improved before this tech-
nique is routinely used in CRC. The most frequently used
tracers in these studies are patent/isosulfan blue, radioac-
tive tracers, or a combination of these. The use of these
tracers poses several problems. Ink (patent/isosulfan blue),
for example, is difficult to detect in mesenteric adipose
tissue, and radioactive tracers have limits when the SLN is
located near the injection site. The spatial resolution of
imaging and the probe detection of radioactive tracers is
limited, which is related to the acquisition method. In
addition, radioactive tracers lack the ability to visualize the
lymph vessels and lymph nodes in real time, which makes
identification of the SLN to be removed problematic.
Near-infrared dyes may have the characteristics to solve
these problems. Near-infrared dyes have a high peak
spectral absorption. Wavelengths in the near-infrared range
penetrate deeply into living tissue compared with visible
light, so SLN staining also can be accurately assessed in
mesenteric adipose tissue. The limitation of this technique
until currently has been the absence of a dedicated device
capable of detecting fluorescent dyes intraoperatively dur-
ing laparoscopic surgery.
This study investigated the feasibility of laparoscopic
SLN detection in the sigmoid by using fluorescence tech-
niques in an acute goat model. A goat model was chosen
because of the fatty mesentery, which is analogous to the
human mesentery.
Methods
A laparoscopic near-infrared fluorescence imaging system
(Olympus Corp., Tokyo, Japan) was newly developed for
this study and optimized for in vivo SLN detection with
indocyanine green (ICG). The system consists of a xenon
light source for excitation, filters for optimal light selec-
tion, a laparoscope, and a camera head. The lenses of the
optical system are specially coated to establish near-
infrared light transparency. Switches positioned at the
camera head can be used to change the filters, so the system
is both white light and near-infrared compatible. All pro-
cedures were recorded.
Six mature female Dutch milk goats (63–90 kg) inclu-
ded in a spinal fusion trial were used for the current study.
All the animals were killed immediately after the proce-
dure, and autopsy was performed. For ICG injection, a long
needle was used in the four cases of percutaneous injection,
whereas an R-scope (Olympus Corp.) was used in the two
colonoscopy procedures.
Surgical technique
The operative procedure and animal care were performed
in compliance with the regulations of the Dutch legislation
for animal research, and the study protocol was approved
by the Animal Ethics Committee of the VU University
Medical Center Amsterdam.
Premedication by intramuscular injection comprising
1.5 mg of atropine and 900 mg of ketamine was adminis-
tered 20 min before surgery, whereas induction was
achieved with intravenous etomidaat 10 to 20 mg, with
adjustment guided by effect. One bolus injection of 250 lg
fentanyl was administered intravenously (IV) and 15 mg
midozolam was administered IV and repeated as needed.
Anesthesia then was maintained with 1.5–2% isoflurane
after insertion of an endotracheal tube. Breathing support
was adjusted to a pressure of 0/15 to 0/20 cm H2O, a
volume of ±8 to 10 ml/kg, a frequency of 14–18 breaths/
min, and a carbon dioxide level of 4.0–4.5%.
Surgery was performed with the animals under general
anesthesia with endotracheal intubation. The goats were
placed in a right lateral decubitus position, and the
abdominal area of the left site was shaved. Three trocars
were used. Percutaneously, a urine catheter was placed into
the stomach rumen to get rid of the gas produced by the
fermentation going on in the rumen.
The sigmoid colon and mesocolon were exposed and
studied. During the first two experiments, 25 mg of ICG
(ICG-PULSION, Pulsion Medical Systems AG, Munchen,
Germany) diluted in 5 ml of 0.9% NaCl was used. We
injected, respectively, 5.0 and 2.5 ml of solution through
the skin into the wall of the sigmoid using a long needle.
During the following two experiments, the sigmoid was
fixed to the abdominal wall using three stitches, posi-
tioning the mesocolon in sight. In these two experiments,
2.5 mg of ICG in 1 ml of 0.9% NaCl containing 2% of
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human serum albumin (HSA) (Cealb, Sanquin, Amster-
dam, The Netherlands) was injected subserosally in the
wall of the viscera using the long needle transcutaneously.
For the subsequent two experiments, we used an R-scope
(Olympus Corp.) inserted per ano into the colon and
maneuvered such that the tip with its working channels was
positioned at the apex of the exposed sigmoid loop. Under
direct vision (both intraluminally and intraperitoneally),
2.5 mg of ICG in 1 ml of 0.9% NaCl/2% HSA was injected
submucosally. Before and after the administration of ICG,
1 ml of NaCl was injected. The first injection of NaCl was
used as a control for positioning the needle, and the second
injection of NaCl was considered to be helpful against
leakage of ICG into the lumen. In all the experiments, the
mesentery was observed with both normal and near-infrared
vision for visualizing the efferent lymph vessels and, sub-
sequently, lymph node dye uptake.
Results
In all the experiments, the efferent draining lymph vessels
were visualized by their bright fluorescence immediately
after the ICG injection. We did not see any autofluores-
cence of the intraabdominal structures. There was a high
signal-to-noise ratio, making it easy to detect ICG in the
abdominal cavity.
During the first two experiments, no lymph nodes were
detected. There was some difficulty to reach the radix and
obtain a clear vision of the mesocolon. In both cases, a
handport was made to assist during the search for lymph
nodes. In addition, some dye spilled into the abdominal
cavity. Due to the spillage, the whole abdominal cavity
eventually took on a bright fluorescent appearance, espe-
cially where the folds of the colon were positioned, and the
procedures therefore were adapted (see ‘‘Methods’’ section).
Despite the spillage, the lymph vessels were easily detected.
During the following two experiments, we were able to
identify one sentinel node in both cases 12 and 8 min after
injection. We could follow the fluorescent vessels, which
ended in a bright fluorescent spot in the mesentery (Fig. 1).
The sentinel node was not seen in ordinary white light
mode, but could be detected easily using the near-infrared
feature of the scope (Fig. 2). When the peritoneum and the
mesenterial fatty tissue were opened, the fluorescent spots
became even more bright (Fig. 3), and the lymph nodes
then also could be identified by normal light.
Subsequent to the autopsy 2 h after injection, the sig-
moid was examined in a laparoscopic training box. In both
specimens, the sentinel nodes could be detected ex vivo. In
one case, a second echelon lymph node was seen that had
not been observed during the in vivo experiment. This
discolored lymph node was located deep at the base of the
radix mesentery. All the fluorescent lymph nodes were
harvested.
We also compared the fluorescent SLNs with other
regional lymph nodes using the near-infrared features of
the scope. No fluorescent signal was detected in any of the
regional lymph nodes. Ex vivo experiments showed a
penetration depth of at least 7 mm through fat tissue.
During our final two experiments, ICG was injected
submucosally by colonoscopy. The ICG formulation was
similar to that of our third and fourth experiments. In both
procedures, a sentinel node became visible after 10 min
(Table 1).
Discussion
In the treatment of colon cancer, SLN detection could have
a future role. As a prerequisite, it should be possible to
identify and harvest the SLN in an accurate, safe, fast, and
reliable manner. Previous publications showed this as a
point of concern [9, 10].
The methods used for SLN mapping to date face some
difficulties that could influence their accuracy in identify-
ing the SLN. As in breast cancer and melanoma, both
radio- and dye-guided imaging have been used for SLN
detection in patients with colon cancer. The ink-based
tracers have a poor tissue contrast and tend to diffuse
through the lymph nodes because of their small particle
size. On the other hand, radio-guided imaging faces the
problem of signal interference of the injection site if the
Fig. 1 View obtained during experiment 3 at 12 min after injection
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SLN is located near the tumor. In addition, the lymph
vessels and lymph nodes cannot be visualized in real time.
Near-infrared dyes may possess the characteristics nee-
ded to solve these problems. Indocyanine green, a water-
soluble tricarbocyanine approved for clinical use, has a
peak spectral absorption at 800–810 nm in blood plasma
and blood. Wavelengths in the 800-nm range penetrate
deeply into living tissue compared with visible light. This
makes it possible to detect the SLN accurately in mesen-
teric adipose tissue. The lymphatic collection process is
strongly related to particle size. Nakajima et al. [11] con-
sidered 40 nm to be the most appropriate bead size for SLN
detection in rats.
In our study, when ICG was dissolved in a NaCl/2%
HSA solution before administration, the dye stayed
entrapped in the SLN. It seemed that ICG diluted in 0.9%
NaCl without HAS was not suitable for SLN identification.
However, confirmatory studies on this topic are needed.
The second echelon lymph node missed in vivo but found
during ex vivo evaluation was located at the radix mes-
entery. The presence of four subsequential stomachs and
the anatomic properties of the radix of the goat colon make
a proper surgical exposure extremely difficult. As another
explanation, uptake of ICG in this lymph node may have
occurred after the in vivo observation period.
The injection volume and concentration of ICG for
optimal clinical use need to be validated in the future. One
of the major challenges in using a percutaneous injection
method is to avoid leakage of dye during and after injec-
tion. Once spillage occurs, the whole abdominal cavity will
be contaminated. When the dye is spilled, it is very hard to
wash away. The background fluorescence of the spilled
material will complicate the detection of the SLN. An
alternative method could be the submucosal injection
during colonoscopy. When leakage occurs with this pro-
cedure, it will be in the lumen and not in the abdominal
cavity. But even then, fluorescence will be seen through the
colon wall.
Fig. 2 View obtained during experiment 3 at 15 min after injection
Fig. 3 View obtained during experiment 3 at 20 min after injection
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The development of intraoperative photodetection could
pave the way to perfect minimally invasive surgery. The
group of Marescaux [12] successfully used the technique of
natural orifice transluminal surgery (NOTES) for sentinel
biopsy of the colon in six pigs. Methylene blue was used
for detection of the lymph vessels and SLNs. However, as
discussed earlier, this may not be the preferred dye for
humans with a fatty mesentery, so such positive results are
not likely to be expected in the clinical situation. In the
near future, early colon cancers may be treated by local
resection therapy alone with a minimally invasive surgical
sentinel node procedure using fluorescent dyes [2].
New fluorescent dyes are being developed by industries
all over the world. Most of them are facing toxicology
studies and will not be available for clinical evaluation in
the near future. But a few fluorescent dyes already are
available commercially for clinical use [2]. With the
development of the new near-infrared laparoscope, intra-
operative visualization of these dyes has become possible.
New applications can be explored by using these dyes
conjugated to monoclonal antibodies. Fluorescent imaging
may provide the surgeon with a tool for intraoperative
detection and diagnostic methods for cancer irradiation.
Conclusions
Before clinical implementation, the sentinel node proce-
dure for patients with colon cancer needs to be improved.
The fluorescent technique seems to be a very promising
new method. Intraoperative photodetection of the SLN
with the use of fluorescence may overcome many limita-
tions of current techniques. This report presents the feasi-
bility of the SLN technique using fluorescence and a newly
developed near-infrared laparoscope in a goat model. The
next step is to validate this technique in a clinical trial.
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